Category: News
Elements per page 12
The acquisition of Maxxspine Innovative GmbH marks another strategic step in Demetra’s commitment to building integrated surgical workflows for orthopaedic and spine surgeons worldwide. With more than twenty years of experience in advanced spinal…
[MILAN, February 24, 2026] – Demetra marks its tenth anniversary by opening a new phase in its evolution. A milestone that also closely involves Tecres and reinforces a shared vision and value proposition. On…
September 16, 2025 – Demetra, an innovative and independent international medical company leader providing bone cements, spacers and biomaterials for orthopedic applications and orthopedic infection control, announces a strategic asset purchase…
Tecres is pleased to announce its participation in the upcoming European Bone and Joint Infection Society (EBJIS) 2025 Annual Meeting, taking place from 11 to 13 September 2025 at the Bologna Congress Center, Italy. Organized by the European Bone…
Asse 1 – Ricerca, sviluppo e innovazione Azione 1.1.1 “Rafforzare la ricerca e l’innovazione (in collaborazione) tra imprese e organismi di ricerca” Sub A “Rafforzare la ricerca e l’innovazione tra imprese e organismi…
Tecres confirms its participation in the 11th AISOT National Congress, which will take place in Brescia on June 20–21, 2025. This important event fosters dialogue between education, research and innovation in the field of orthopaedics. On Friday,…
Tecres is pleased to make an important new announcement regarding the outstanding medical sector group it is part of, founded and headed by Demetra: the acquisition of a majority shareholding in GetSet™ Surgical, a Swiss company specialising in…
From 13 to 16 October 2024 the annual congress of EANS, The European Association of Neurosurgical Societies, returns. This year, the important scientific meeting will be held in Sofia: in the Bulgarian capital city, neurosurgical specialists and companies…
For surgeons in spinal surgery, EUROSPINE, the annual congress of the Spine Society of Europe, is an important professional event, offering invaluable insights into the latest scientific advancements in the field. It also provides a unique opportunity…
Bone cements from Tecres and biomaterials from Osartis will take centre stage at the traditional EBJIS (European Bone and Joint Infection Society) congress. The two Demetra Group companies will share their expertise in infection control with clinicians…
Once again this year Demetra Holding, with the full participation of its group companies - Tecres, Osartis, OsteoRemedies and Yijiutai - confirmed its commitment to sustainability by undergoing a carbon footprint assessment. In an increasingly data-driven…
Tecres is pleased to announce a commercial partnership with Wiltrom, the Taiwan-based company specialising in medical device design and development. The collaboration expands the range of acrylic resins and accessories for percutaneous vertebroplasty…
You are entering an area dedicated only to medical professionals. Regulatory requirements or medical practices may vary from country to country, as well as legal advice and personal data protection. The informations contained in the area you are about to enter may not be appropriate to use in your country. Clicking on Next, you confirm to be a medical professional and to understand that legal statement and privacy policy could be different from those on your country.
Our site uses cookies to enhance your expérience. To learn more about our cookies, please read our Cookies Policy.
